APA

Lara P. N., Plets M., Tangen C., Gertz E., Vogelzang N. J., Hussain M., Twardowski P. W., Garzotto M. G., Monk J. P., Carducci M., Goldkorn A., Mack P. C., Thompson I., Van Loan M. & Quinn D. I. (2018). Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. : Cancer treatment and research communications.

Chicago

Lara P N, Plets M, Tangen C, Gertz E, Vogelzang N J, Hussain M, Twardowski P W, Garzotto M G, Monk J P, Carducci M, Goldkorn A, Mack P C, Thompson I, Van Loan M and Quinn D I. 2018. Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. : Cancer treatment and research communications.

Harvard

Lara P. N., Plets M., Tangen C., Gertz E., Vogelzang N. J., Hussain M., Twardowski P. W., Garzotto M. G., Monk J. P., Carducci M., Goldkorn A., Mack P. C., Thompson I., Van Loan M. and Quinn D. I. (2018). Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. : Cancer treatment and research communications.

MLA

Lara P N, Plets M, Tangen C, Gertz E, Vogelzang N J, Hussain M, Twardowski P W, Garzotto M G, Monk J P, Carducci M, Goldkorn A, Mack P C, Thompson I, Van Loan M and Quinn D I. Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421. : Cancer treatment and research communications. 2018.